Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial

Peer review reports

Original Submission
23 Sep 2020	Submitted	Original manuscript
23 Sep 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
24 Sep 2020	Editorially accepted
15 Oct 2020	Article published	10.1186/s13063-020-04775-4

Back to article page